Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 2374
TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363028(US9850203, Compound 2-57 | US9850203, Compound 2-5...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363028(US9850203, Compound 2-57 | US9850203, Compound 2-5...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363027(US9850203, Compound 2-56 | 6-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363028(US9850203, Compound 2-57 | US9850203, Compound 2-5...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363033(US9850203, Compound 2-62 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363034(US9850203, Compound 2-63 | 3-((6-Chloro-1-(2-(3-cy...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363031(US9850203, Compound 2-60 | 3-((6-Chloro-1-(2-(2,3-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363032(US9850203, Compound 2-61 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363021(US9850203, Compound 1-98 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363022(US9850203, Compound 2-1 | 6-((6-Chloro-7-fluoro-2-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363019(US9850203, Compound 1-96 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363020(US9850203, Compound 1-97 | 3-((6-Chloro-1-(2-(2,3-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363025(US9850203, Compound 2-54 | 6-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363026(US9850203, Compound 2-55 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363023(US9850203, Compound 2-3 | Methyl 6-((6-chloro-7-fl...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363024(US9850203, Compound 2-45 | 3-((2,6-dichloro-7-fluo...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363045(US9850203, Compound 2-74 | 3-((6-chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363046(US9850203, Compound 2-75 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363043(US9850203, Compound 2-72 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363044(US9850203, Compound 2-73 | 3-((6-chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363049(US9850203, Compound 3-104 | 6-((6-Chloro-7-fluoro-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363050(US9850203, Compound 3-220 | 3-((6-Chloro-7-fluoro-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363047(US9850203, Compound 3-23 | 3-[6-Chloro-7-fluoro-1-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363048(US9850203, Compound 3-96 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363037(US9850203, Compound 2-66 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363038(US9850203, Compound 2-67 | 3-((6-Chloro-1-(2-(3-cy...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363035(US9850203, Compound 2-64 | (R)-3-((6-Chloro-7-fluo...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363036(US9850203, Compound 2-65 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363041(US9850203, Compound 2-70 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363042(US9850203, Compound 2-71 | 3-((6-Chloro-1-(2-(3-((...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363039(US9850203, Compound 2-68 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363040(US9850203, Compound 2-69 | 3-((6-Chloro-1-(2-((3S,...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363061(US9850203, Compound 5-6 | 3-((6-chloro-2-cycloprop...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363059(US9850203, Compound 5-4 | 3-((6-chloro-2-cycloprop...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363060(US9850203, Compound 5-5 | 3-((2,6-dichloro-7-fluor...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363053(US9850203, Compound 4-85 | 3-((6-chloro-2-cyclopro...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363054(US9850203, Compound 4-121 | 3-((2,6-dichloro-7-flu...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363051(US9850203, Compound 3-221 | 3-((6-Chloro-7-fluoro-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363052(US9850203, Compound 4-29 | 3-((6-chloro-2-cyclopro...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363057(US9850203, Compound 5-2 | 3-((2,6-dichloro-7-fluor...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363058(US9850203, Compound 5-3 | 3-((6-chloro-2-cycloprop...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363055(US9850203, Compound 4-129 | 3-((6-chloro-2-cyclopr...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM363056(US9850203, Compound 5-1 | 3-((2,6-dichloro-7-fluor...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362932(US9850203, Compound 1-1 | 3-((6-Chloro-7-fluoro-1-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362949(US9850203, Compound 1-16 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362946(US9850203, Compound 1-13 | 3-((6-Chloro-1-(2-(4-((...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362947(US9850203, Compound 1-14 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362952(US9850203, Compound 1-19 | 3-((6-Chloro-1-(2-(2-cy...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362953(US9850203, Compound 1-20 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362951(US9850203, Compound 1-18 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
US Patent

Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: